Updated treatment options for gastroesophageal reflux disease in children: practical guide for clinicians
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pediatric reflux esophagitis (RE) requires age-specific management distinct from adults. A stepwise approach, starting with non-pharmacologic methods and cautious medication use, improves outcomes and minimizes harm in children.
Area Of Science
- Pediatric Gastroenterology
- Gastroesophageal Reflux Disease (GERD) Management
- Reflux Esophagitis (RE) in Children
Background
- Pediatric reflux esophagitis (RE) is a distinct entity within the broader spectrum of gastroesophageal reflux disease (GERD), differing significantly from adult presentations in pathophysiology, clinical manifestation, and therapeutic risk-benefit profiles.
- There is a critical need for clear, age-appropriate clinical guidelines to address the diagnosis and management of RE in pediatric populations.
Purpose Of The Study
- To synthesize current guidelines and research findings on the diagnosis and management of pediatric reflux esophagitis.
- To provide an age-aware, stepwise strategy for optimizing treatment outcomes while minimizing potential harm in children with RE.
Main Methods
- Narrative review of guidelines and studies identified through PubMed/Embase searches up to 2025.
- Keywords included pediatric GERD/RE, diagnostic methods (endoscopy, pH monitoring, pH-impedance), pharmacotherapy, safety profiles, and surgical interventions.
Main Results
- Diagnostic approaches include endoscopy with biopsy and ambulatory monitoring (pH for acid, pH-impedance for nonacid reflux).
- First-line management focuses on feeding optimization, thickeners, allergy evaluation, and positional advice.
- Pharmacotherapy options range from proton-pump inhibitors (PPIs) for children ≥1 year with documented esophagitis to H2-receptor antagonists, alginates, and selective use of prokinetics or baclofen for refractory cases. Emerging agents like potassium-competitive acid blockers (P-CABs) are under evaluation.
Conclusions
- An age-aware, stepwise strategy prioritizing non-pharmacologic interventions, time-limited PPIs with planned step-down, and cautious adjuncts is recommended for pediatric RE.
- Future research priorities include pediatric trials for P-CABs and alginates, development of validated deprescribing guidelines, identification of noninvasive biomarkers, and scalable care models.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...